BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
P/S ratio for BridgeBio Pharma (BBIO)
P/S ratio as of May 2024 (TTM): 560
According to BridgeBio Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 559.798. At the end of 2023 the company had a P/S ratio of 755.
P/S ratio history for BridgeBio Pharma from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 755 | 5046.19% |
| 2022 | 14.7 | -58.34% |
| 2021 | 35.2 | -96.67% |
| 2020 | > 1000 | 889.85% |
| 2019 | 107 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -99.81% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | -83.48% | 🇺🇸 USA |